FAQs & Video Library

Bodi Envi is a LegitScript-certified U.S. telehealth platform that connects eligible patients with licensed healthcare providers for personalized medical weight-management care.

Yes. Bodi Envi is a LegitScript-certified telehealth platform. Licensed healthcare providers make clinical evaluation and prescribing decisions. When treatment is prescribed, fulfillment is handled by an applicable U.S. pharmacy partner.

Yes. Bodi Envi is LegitScript certified.

No. Bodi Envi is a telehealth platform. Clinical services are provided by licensed healthcare providers through applicable clinical provider organizations.

No. Bodi Envi is not a pharmacy. When medication is prescribed, the prescription is sent to an applicable pharmacy for dispensing and fulfillment.

No. Bodi Envi does not manufacture or compound medication.

Licensed healthcare providers provide clinical evaluation and care. Wasef Health, PC provides clinical services for applicable Bodi Envi programs.

Michael Wasef, MD serves as Medical Director for applicable Bodi Envi clinical programs through Wasef Health, PC. Dr. Wasef is a board-certified internal medicine physician.

Bodi Envi is based in Tampa, Florida and provides telehealth services to eligible patients where its clinical and pharmacy partners are authorized to provide care.

Bodi Envi facilitates care through telehealth.

Patients begin with an online health assessment. A licensed healthcare provider reviews the patient's medical information and determines whether treatment is appropriate. When prescribed, medication is sent to an applicable pharmacy for fulfillment.

No. Completing an assessment or paying for a program does not guarantee a prescription. A licensed healthcare provider determines whether prescription treatment is medically appropriate. If you do not qualify, a refund will be issued according to the applicable policy.

Patients receive clinical evaluation by a licensed healthcare provider and can communicate with their care team according to the applicable program's telehealth process.

Bodi Envi patients can communicate with their care team through the patient portal according to the services included in their program.

Current patients receive ongoing medical support and access to the provider team associated with their treatment program.

Yes. A licensed healthcare provider may adjust treatment based on medical history, treatment response, tolerability, and independent clinical judgment. Patients can request changes through support or their care team.

No. Individual responses to treatment vary, and no specific amount of weight loss can be guaranteed.

Medical weight management is a primary Bodi Envi service. Other wellness services may also be available.

Yes. Licensed healthcare providers evaluate individual medical information and determine an appropriate treatment plan based on each patient's needs.

Personalized compounded semaglutide is a compounded GLP-1 receptor agonist program that may be considered by a licensed healthcare provider for eligible patients. FDA-approved semaglutide products exist for specific indications. Compounded semaglutide is a different category of product and is not FDA-approved.

Bodi Envi offers access to medical weight-management programs that may include personalized compounded semaglutide when a licensed healthcare provider determines it is appropriate.

No. Compounded semaglutide is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality. Compounding pharmacies are regulated by applicable state boards of pharmacy.

No. Bodi Envi does not represent compounded semaglutide as equivalent to FDA-approved semaglutide products.

Semaglutide activates GLP-1 receptors involved in appetite, food intake, and glucose regulation. Treatment effects and individual responses vary.

Medication may be administered by subcutaneous injection. Patients should follow the exact instructions provided by their healthcare provider and dispensing pharmacy.

It is commonly prescribed on a weekly schedule, but patients must follow their individual prescription and provider instructions.

Gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort can occur. Patients should discuss potential adverse effects and serious warnings with their healthcare provider.

Compounded semaglutide is not appropriate for everyone. A licensed healthcare provider should review medical history, medications, contraindications, warnings, and individual risk factors before treatment.

Results vary considerably. Your provider can discuss treatment response, progress, and whether a treatment plan remains appropriate for you.

Personalized compounded tirzepatide has activity at GIP and GLP-1 receptors involved in appetite and metabolic regulation. FDA-approved tirzepatide products exist for specific indications. Compounded tirzepatide is not FDA-approved.

Yes. Bodi Envi offers medical weight-management programs that may include personalized compounded tirzepatide when a licensed healthcare provider determines it is appropriate.

No. Compounded tirzepatide is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality. Compounding pharmacies are regulated by applicable state boards of pharmacy.

No. Bodi Envi does not represent compounded tirzepatide as equivalent to FDA-approved tirzepatide products, including Zepbound or Mounjaro.

Tirzepatide activates GIP and GLP-1 receptors involved in appetite and metabolic regulation. Treatment effects and individual responses vary.

It is commonly prescribed on a weekly schedule, but patients must follow the individual instructions provided by their healthcare provider and dispensing pharmacy.

Common adverse effects can include nausea, diarrhea, vomiting, constipation, decreased appetite, and abdominal symptoms. Other side effects can occur. Patients should discuss risks and warnings with their healthcare provider.

Compounded tirzepatide is not appropriate for everyone. Eligibility is determined by a licensed healthcare provider after reviewing medical history, medications, contraindications, and individual risk factors.

Results vary considerably. Your provider can discuss treatment response, progress, and whether a treatment plan remains appropriate for you.

Neither option is automatically better for every patient. The medications have different pharmacology, and a licensed healthcare provider determines what may be appropriate based on individual circumstances.

A compounded medication is prepared by a compounding pharmacy for an individual patient prescription or other circumstances permitted under applicable law. Compounded drugs are not FDA-approved.

No. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality.

No. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed in the same way it reviews FDA-approved drugs.

Not necessarily. A compounded drug should not automatically be described as a generic version of an FDA-approved drug.

No. Compounded GLP-1 medications are not FDA-approved and should not be represented as equivalent to FDA-approved products.

A licensed healthcare provider may determine that a compounded medication is appropriate for an individual patient when permitted under applicable law and based on that patient's medical needs.

No. Bodi Envi does not manufacture or compound medications. Bodi Envi is a telehealth platform that connects eligible patients with licensed healthcare providers for clinical evaluation.

Bodi Envi works with applicable U.S. pharmacy partners. VialsRx is a pharmacy partner for applicable GLP-1 prescriptions. The dispensing pharmacy may depend on the patient's prescription, program, and location.

No. VialsRx is a separate pharmacy organization and is not Bodi Envi.

Medication is dispensed and shipped by the applicable dispensing pharmacy according to the prescription and pharmacy procedures.

No. Bodi Envi is the telehealth platform. Prescription fulfillment and medication shipping are handled by the applicable dispensing pharmacy.

Shipping times vary based on prescription processing, pharmacy operations, patient location, holidays, and other factors. Refer to current shipping information or contact support for help with a specific order.

The dispensing pharmacy is identified on medication packaging and prescription documentation. Patients may also contact the care or support team with fulfillment questions.

Bodi Envi publishes current program pricing on its treatment and pricing pages. Because pricing can change, review the current treatment page before enrolling or email info@bodienvi.com with specific questions.

Current Bodi Envi pricing does not increase based on dosage strength for applicable programs. Refer to the current treatment page for exact pricing and availability.

Current program pricing includes expedited shipping where stated on the applicable treatment page.

The licensed provider evaluation and medication are included when stated in the current applicable program pricing. Review the applicable treatment page for current details.

Bodi Envi offers applicable self-pay programs that do not require health insurance.

Eligible healthcare expenses may qualify for HSA or FSA reimbursement depending on the expense and your plan. Verify eligibility with your plan administrator. For a superbill request, email info@bodienvi.com.

Bodi Envi aims to provide transparent pricing. Review the current treatment page and checkout details for your selected program.

Yes. You can request cancellation through your patient portal, by emailing info@bodienvi.com, or by calling 1-855-348-2630.

Compounded GLP-1 medications are not FDA-approved and do not undergo FDA premarket review. A licensed healthcare provider reviews individual medical information and can discuss potential benefits, risks, warnings, and alternatives.

Contact your licensed healthcare provider if you experience side effects. Do not independently change treatment. For a medical emergency, call 911 or seek immediate emergency care.

Nausea can occur with GLP-1 treatment. Discuss persistent, severe, or concerning symptoms with your healthcare provider rather than independently changing treatment. Your provider can discuss appropriate care options based on your clinical situation.

Possibly. A licensed healthcare provider may adjust dosing or treatment based on your symptoms, medical history, tolerability, and independent clinical judgment.

Long-term weight-management plans are individualized. A healthcare provider can discuss maintenance, lifestyle strategies, and whether treatment changes may be appropriate.

Weight regain can occur after weight-management treatment is discontinued. Long-term outcomes vary, and patients should discuss maintenance planning with their healthcare provider.

Medical weight-management treatment is generally used alongside appropriate nutrition, physical activity, and behavioral or lifestyle strategies based on individual circumstances.

Start with Bodi Envi's health assessment. A licensed healthcare provider can evaluate your health information and determine whether an available treatment option may be appropriate. Completing an assessment does not guarantee a prescription.